{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:12:30Z","timestamp":1784563950336,"version":"3.55.0"},"reference-count":69,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NSFC","award":["81170145"],"award-info":[{"award-number":["81170145"]}]},{"name":"NSFC","award":["81470436"],"award-info":[{"award-number":["81470436"]}]},{"name":"Medcen Community Health Foundation of Georgia","award":["81170145"],"award-info":[{"award-number":["81170145"]}]},{"name":"Medcen Community Health Foundation of Georgia","award":["81470436"],"award-info":[{"award-number":["81470436"]}]},{"name":"Seed grants from Mercer University School of Medicine","award":["81170145"],"award-info":[{"award-number":["81170145"]}]},{"name":"Seed grants from Mercer University School of Medicine","award":["81470436"],"award-info":[{"award-number":["81470436"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Angiotensin II (Ang II), a peptide hormone generated as part of the renin\u2013angiotensin system, has been implicated in the pathophysiology of many cardiovascular diseases such as peripheral artery disease, heart failure, hypertension, coronary artery disease and other conditions. Liraglutide, known as an incretin mimetic, is one of the glucagon-like peptide-1 (GLP-1) receptor agonists, and has been proven to be effective in the treatment of cardiovascular disorders beyond adequate glycemic control. The objective of this review is to compile our recent experimental outcomes-based studies, and provide an overview the cardiovascular protection from liraglutide against Ang II- and pressure overload-mediated deleterious effects on the heart. In particular, the mechanisms of action underlying the inhibition of oxidative stress, vascular endothelial dysfunction, hypertension, cardiac fibrosis, left ventricular hypertrophy and heart failure with liraglutide are addressed. Thus, we support the notion that liraglutide continues to be a useful add-on therapy for the management of cardiovascular diseases.<\/jats:p>","DOI":"10.3390\/molecules28031369","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T01:36:59Z","timestamp":1675215419000},"page":"1369","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update"],"prefix":"10.3390","volume":"28","author":[{"given":"Collin","family":"Vandemark","sequence":"first","affiliation":[{"name":"Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, GA 31404, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, GA 31404, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Qing","family":"Zhao","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, GA 31404, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"115263","DOI":"10.1016\/j.bcp.2022.115263","article-title":"Endothelial and vascular smooth muscle dysfunction in hypertension","volume":"205","author":"Nadruz","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e148556","DOI":"10.1172\/JCI148556","article-title":"Targeting the vasculature in cardiometabolic disease","volume":"132","author":"Boutagy","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/bs.apha.2017.08.012","article-title":"Basic components of vascular connective tissue and extracellular matrix","volume":"81","author":"Halper","year":"2018","journal-title":"Adv Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajh\/hpaa137","article-title":"Aldosterone, inflammation, immune system, and hypertension","volume":"34","author":"Ferreira","year":"2021","journal-title":"Am. J. Hypertens."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e148554","DOI":"10.1172\/JCI148554","article-title":"Therapeutic targets for cardiac fibrosis: From old school to next-gen","volume":"132","author":"Travers","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_6","first-page":"103992","article-title":"Inflammation and resolution signaling in cardiac repair and heart failure","volume":"79","author":"Halade","year":"2022","journal-title":"EBio Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"952178","DOI":"10.3389\/fcvm.2022.952178","article-title":"Macrophage-extracellular matrix interactions: Perspectives for tissue engineered heart valve remodeling","volume":"9","author":"Poulis","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: Physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s10741-021-10137-2","article-title":"Current and emerging drug targets in heart failure treatment","volume":"27","author":"Ghionzoli","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10557-020-07088-5","article-title":"Glucagon-like peptide-1 analog liraglutide attenuates pressure-overload induced cardiac hypertrophy and apoptosis through activating ATP sensitive potassium channels","volume":"35","author":"Bai","year":"2021","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"173318","DOI":"10.1016\/j.ejphar.2020.173318","article-title":"Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR\/p70S6K signaling and promoting autophagy","volume":"883","author":"Zheng","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ahj.2012.02.016","article-title":"Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treatment of ischemic heart disease: Future research needs prioritization","volume":"163","author":"Crowley","year":"2012","journal-title":"Am. Heart J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.amjmed.2008.02.038","article-title":"Angiotensin receptor blockers: Current status and future prospects","volume":"121","author":"Ram","year":"2008","journal-title":"Am. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): A multicentre, randomised, double-blind, controlled trial","volume":"372","author":"Mann","year":"2008","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/14789450.2018.1545577","article-title":"Advances in understanding the role of angiotensin-regulated proteins in kidney diseases","volume":"16","author":"Sanz","year":"2019","journal-title":"Expert Rev. Proteom."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/cmdc.201700781","article-title":"Glucagon-like peptide-1 (GLP-1)-based therapeutics: Current status and future opportunities beyond type 2 diabetes","volume":"13","author":"Cheang","year":"2018","journal-title":"ChemMedChem"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.biopha.2018.08.088","article-title":"Recent updates on GLP-1 agonists: Current advancements & challenges","volume":"108","author":"Sharma","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10557-015-6592-7","article-title":"Preservation of glucagon-like peptide-1 level attenuates angiotensin II-induced tissue fibrosis by altering AT1\/AT 2 receptor expression and angiotensin-converting enzyme 2 activity in rat heart","volume":"29","author":"Zhang","year":"2015","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.lfs.2016.04.013","article-title":"Angiotensin II AT1 receptor alters ACE2 activity, eNOS expression and CD44-hyaluronan interaction in rats with hypertension and myocardial fibrosis","volume":"153","author":"Bai","year":"2016","journal-title":"Life Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuint.2019.04.010","article-title":"GLP-1: Molecular mechanisms and outcomes of a complex signaling system","volume":"128","author":"Smith","year":"2019","journal-title":"Neurochem. Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/TP.0000000000002448","article-title":"Liraglutide, a glucagon-like peptide-1 receptor agonist, attenuates development of cardiac allograft vasculopathy in a murine heart transplant model","volume":"103","author":"Wang","year":"2019","journal-title":"Transplantation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cbi.2018.01.004","article-title":"Coagonist of GLP-1 and glucagon decreases liver inflammation and atherosclerosis in dyslipidemic condition","volume":"282","author":"Patel","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.rmed.2019.06.015","article-title":"Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patients","volume":"154","author":"Rogliani","year":"2019","journal-title":"Respir. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/CIRCULATIONAHA.117.028136","article-title":"Cardiovascular actions and clinical outcomes with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors","volume":"136","author":"Nauck","year":"2017","journal-title":"Circulation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"28668","DOI":"10.1074\/jbc.M113.470971","article-title":"Nox4 NADPH oxidase mediates peroxynitrite-dependent uncoupling of endothelial nitric-oxide synthase and fibronectin expression in response to angiotensin II: Role of mitochondrial reactive oxygen species","volume":"288","author":"Lee","year":"2013","journal-title":"Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/HYPERTENSIONAHA.119.14400","article-title":"DPP (dipeptidyl peptidase)-4 inhibitor attenuates Ang II (angiotensin II)-induced cardiac hypertrophy via GLP (glucagon-like peptide)-1-dependent suppression of Nox (nicotinamide adenine dinucleotide phosphate oxidase) 4-HDAC (histone deacetylase) 4 pathway","volume":"75","author":"Okabe","year":"2020","journal-title":"Hypertension"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"175048","DOI":"10.1016\/j.ejphar.2022.175048","article-title":"Suppression of angiotensin II-activated NOX4\/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis and hypertension","volume":"927","author":"Banks","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: An update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1470320317706653","DOI":"10.1177\/1470320317706653","article-title":"Recruitment of macrophages from the spleen contributes to myocardial fibrosis and hypertension induced by angiotensin II","volume":"18","author":"Wang","year":"2017","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"ref_33","first-page":"6043","article-title":"Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1\/AT2 receptors and ACE2 in rats","volume":"9","author":"Pang","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.2147\/DDDT.S213910","article-title":"Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats","volume":"13","author":"Zheng","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"H3103","DOI":"10.1152\/ajpheart.00456.2006","article-title":"Interleukin-10 counteracts impaired endothelium-dependent relaxation induced by ANG II in murine aortic rings","volume":"292","author":"Zemse","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/sj.bjp.0705669","article-title":"The role of bradykinin, AT2 and angiotensin 1-7 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat","volume":"141","author":"Resende","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Bhullar, S.K., and Dhalla, N.S. (2022). Angiotensin II-induced signal transduction mechanisms for cardiac hypertrophy. Cells, 11.","DOI":"10.3390\/cells11213336"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ejhf.1715","article-title":"Hypertrophic cardiomyopathy: The future of treatment","volume":"22","author":"Tuohy","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Kurose, H. (2021). Cardiac fibrosis and fibroblasts. Cells, 10.","DOI":"10.3390\/cells10071716"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.trsl.2019.03.004","article-title":"Mechanisms of cardiac collagen deposition in experimental models and human disease","volume":"209","author":"Cowling","year":"2019","journal-title":"Transl Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1159\/000107757","article-title":"From mitochondria to disease: Role of the renin-angiotensin system","volume":"27","author":"Inserra","year":"2007","journal-title":"Am. J. Nephrol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.2174\/1381612811319170008","article-title":"Redox control of cardiovascular homeostasis by angiotensin II","volume":"19","author":"Sunggip","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/CIRCRESAHA.119.315767","article-title":"Mitochondrial deacetylase Sirt3 reduces vascular dysfunction and hypertension while Sirt3 depletion in essential hypertension Is linked to vascular inflammation and oxidative stress","volume":"126","author":"Dikalova","year":"2020","journal-title":"Circ. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.1016\/j.exger.2012.08.007","article-title":"SIRT3 regulation of mitochondrial oxidative stress","volume":"48","author":"Bause","year":"2013","journal-title":"Exp. Gerontol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.freeradbiomed.2017.08.010","article-title":"Ellagic acid antagonizes Bnip3-mediated mitochondrial injury and necrotic cell death of cardiac myocytes","volume":"112","author":"Dhingra","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCRESAHA.114.302022","article-title":"Mammalian target of rapamycin signaling in cardiac physiology and disease","volume":"114","author":"Sciarretta","year":"2014","journal-title":"Circ. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2015.03.001","article-title":"The S6K protein family in health and disease","volume":"131","author":"Tavares","year":"2015","journal-title":"Life Sci."},{"key":"ref_49","first-page":"3705","article-title":"Effect of autophagy on myocardial infarction and its mechanism","volume":"21","author":"Aisa","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yjmcc.2018.10.004","article-title":"Curcumin protects against diabetic cardiomyopathy by promoting autophagy and alleviating apoptosis","volume":"124","author":"Yao","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_51","first-page":"1468","article-title":"Pharmacological restoration of autophagy reduces hypertension-related stroke occurrence","volume":"12","author":"Forte","year":"2019","journal-title":"Autophagy"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1530\/JME-16-0086","article-title":"The role of autophagy in angiotensin II-induced pathological cardiac hypertrophy","volume":"57","author":"Zhou","year":"2016","journal-title":"J. Mol. Endocrinol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1080\/15548627.2015.1106668","article-title":"MTOR, PIK3C3, and autophagy: Signaling the beginning from the end","volume":"11","author":"Munson","year":"2015","journal-title":"Autophagy"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.biopha.2018.06.129","article-title":"Vascular endothelial growth factor over-expressed mesenchymal stem cells-conditioned media ameliorate palmitate-induced diabetic endothelial dysfunction through PI-3K\/AKT\/m-TOR\/eNOS and p38\/MAPK signaling pathway","volume":"106","author":"Xu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.exger.2017.08.001","article-title":"Interaction between mTOR pathway inhibition and autophagy induction attenuates adriamycin induced vascular smooth muscle cell senescence through decreased expression of p53\/p21\/p16","volume":"109","author":"Sung","year":"2018","journal-title":"Exp. Gerontol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: A pharmacologic target for autophagy regulation","volume":"125","author":"Kim","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/annrheumdis-2013-204599","article-title":"Cartilage specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis","volume":"74","author":"Zhang","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.biocel.2004.05.009","article-title":"LC3 conjugation system in mammalian autophagy","volume":"36","author":"Tanida","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/s41467-018-03939-w","article-title":"A novel autophagy enhancer as a therapeutic agent against metabolic syndrome and diabetes","volume":"9","author":"Lim","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1161\/CIRCULATIONAHA.117.032821","article-title":"Beclin-1-dependent autophagy protects the heart during sepsis","volume":"138","author":"Sun","year":"2018","journal-title":"Circulation"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1007\/s11255-019-02274-3","article-title":"Liraglutide promotes autophagy by regulating the AMPK\/mTOR pathway in a rat remnant kidney model of chronic renal failure","volume":"51","author":"Xue","year":"2019","journal-title":"Int. Urol. Nephrol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1161\/CIRCRESAHA.116.304937","article-title":"Mechanotransduction in cardiac hypertrophy and failure","volume":"116","author":"Lyon","year":"2015","journal-title":"Circ. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pcad.2019.11.009","article-title":"Left ventricular hypertrophy and hypertension","volume":"63","author":"Yildiz","year":"2020","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Gallo, S., Vitacolonna, A., Bonzano, A., Comoglio, P., and Crepaldi, T. (2019). ERK: A key player in the pathophysiology of cardiac hypertrophy. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092164"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jchf.2017.04.012","article-title":"The transition from hypertension to heart failure: Contemporary update","volume":"8","author":"Messerli","year":"2017","journal-title":"JACC Heart Fail."},{"key":"ref_66","first-page":"e003201","article-title":"Elevated plasma GLP-1 levels and enhanced expression of cardiac GLP-1 receptors as markers of left ventricular systolic dysfunction: A cross-sectional study","volume":"3","author":"Hattori","year":"2013","journal-title":"BMJ"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"101102","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes\u2014state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s40265-019-01148-3","article-title":"Dapagliflozin: A review in type 2 diabetes","volume":"79","author":"Dhillon","year":"2019","journal-title":"Drugs"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/eurheartj\/ehab798","article-title":"Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction","volume":"43","author":"Butler","year":"2022","journal-title":"Eur. Heart J."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/3\/1369\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:20:28Z","timestamp":1760120428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/3\/1369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":69,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["molecules28031369"],"URL":"https:\/\/doi.org\/10.3390\/molecules28031369","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]}}}